Idol Biotec Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 27-06-2024
- Paid Up Capital ₹ 2.10 M
as on 27-06-2024
- Company Age 19 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 1.00 Cr
as on 27-06-2024
- Satisfied Charges ₹ 2.65 M
as on 27-06-2024
- Revenue -38.96%
(FY 2021)
- Profit -37.89%
(FY 2021)
- Ebitda -33.70%
(FY 2021)
- Net Worth 4.54%
(FY 2021)
- Total Assets -8.35%
(FY 2021)
About Idol Biotec
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.10 M.
The company currently has active open charges totaling ₹1.00 Cr. The company has closed loans amounting to ₹2.65 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Sharma, Hari Sharma, and Geetanjali Sharma serve as directors at the Company.
- CIN/LLPIN
U51397RJ2005PTC020459
- Company No.
020459
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Mar 2005
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- LocationKota, Rajasthan
- Telephone
- Email Address
- Website
-
- Social Media
Who are the key members and board of directors at Idol Biotec?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Sharma  | Director | 18-Mar-2005 | Current |
| Hari Sharma | Director | 18-Mar-2005 | Current |
| Geetanjali Sharma | Director | 18-Mar-2005 | Current |
Financial Performance of Idol Biotec.
Idol Biotec Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 38.96% decrease. The company also saw a substantial fall in profitability, with a 37.89% decrease in profit. The company's net worth moved up by a moderate rise of 4.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Idol Biotec?
In 2021, Idol Biotec had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 05 Jun 2013 | ₹1.00 Cr | Open |
State Bank Of Bikaner & Jaipur Creation Date: 03 May 2011 | ₹2.65 M | Satisfied |
How Many Employees Work at Idol Biotec?
Idol Biotec has a workforce of 3 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Idol Biotec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Idol Biotec's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
